USP26 and carcinoma: The data obtained in this study reveal that RAC1B effectively inhibits TGFβ1-dependent cell motility of mesenchymal subtype carcinoma cells by promoting protein expression of the inhibitory Smad, SMAD7, via intermittent transcriptional induction of the deubiquitinating enzyme, USP26.